We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Vertex Pharmaceuticals Inc | BOV:VRTX34 | Bovespa | Depository Receipt |
Price Change | % Change | Price | Bid Price | Offer Price | |
---|---|---|---|---|---|
-1.69 | -0.33% | 510.51 | 540.00 |
High Price | Low Price | Open Price | Traded | Last Trade |
---|---|---|---|---|
510.51 | 510.51 | 510.51 | 2 | 00:00:00 |
Date | Price | Price Change | Price % Change | Low Price | High Price | Traded |
---|---|---|---|---|---|---|
03 May 2024 | 510.51 | -1.69 | -0.33% | 510.51 | 510.51 | 2 |
02 May 2024 | 512.20 | 2.20 | 0.43% | 510.12 | 513.24 | 48 |
30 Apr 2024 | 510.00 | 3.67 | 0.72% | 510.00 | 510.51 | 84 |
29 Apr 2024 | 506.33 | -3.16 | -0.62% | 505.41 | 506.33 | 8 |
26 Apr 2024 | 509.49 | -4.35 | -0.85% | 504.00 | 514.86 | 22 |
25 Apr 2024 | 513.84 | -2.03 | -0.39% | 513.84 | 513.84 | 1 |
24 Apr 2024 | 515.87 | -5.17 | -0.99% | 515.87 | 516.36 | 13 |
23 Apr 2024 | 521.04 | -0.18 | -0.03% | 521.04 | 524.16 | 8 |
22 Apr 2024 | 521.22 | 10.41 | 2.04% | 514.08 | 526.32 | 82 |
19 Apr 2024 | 510.81 | -6.59 | -1.27% | 510.81 | 511.68 | 12 |
18 Apr 2024 | 517.40 | 2.06 | 0.40% | 517.40 | 517.40 | 4 |
17 Apr 2024 | 515.34 | -4.14 | -0.80% | 515.34 | 515.34 | 8 |
16 Apr 2024 | 519.48 | 3.36 | 0.65% | 518.00 | 521.00 | 116 |
15 Apr 2024 | 516.12 | 11.73 | 2.33% | 516.12 | 516.63 | 82 |
12 Apr 2024 | 504.39 | -7.11 | -1.39% | 504.39 | 508.46 | 7 |
11 Apr 2024 | 511.50 | 5.24 | 1.04% | 509.00 | 512.50 | 127 |
10 Apr 2024 | 506.26 | 0.96 | 0.19% | 503.22 | 506.30 | 11 |
09 Apr 2024 | 505.30 | -3.48 | -0.68% | 501.50 | 505.50 | 14 |
08 Apr 2024 | 508.78 | -5.81 | -1.13% | 506.50 | 509.00 | 59 |
05 Apr 2024 | 514.59 | 5.61 | 1.10% | 508.98 | 517.14 | 109 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions